Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) insider Patrick Cunningham sold 125,000 shares of the company’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $7.59, for a total transaction of $948,750.00. Following the transaction, the insider directly owned 212,755 shares of the company’s stock, valued at approximately $1,614,810.45. This trade represents a 37.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Aveanna Healthcare Trading Down 0.1%
Shares of NASDAQ:AVAH traded down $0.01 during midday trading on Thursday, hitting $7.67. 1,003,505 shares of the stock traded hands, compared to its average volume of 1,313,309. The business’s 50 day moving average is $6.74 and its two-hundred day moving average is $7.87. The stock has a market capitalization of $1.67 billion, a PE ratio of 6.50, a P/E/G ratio of 0.91 and a beta of 1.93. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. Aveanna Healthcare Holdings Inc. has a one year low of $3.73 and a one year high of $10.32.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. The business had revenue of $647.92 million during the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The business’s revenue was up 15.9% compared to the same quarter last year. As a group, research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.56 earnings per share for the current year.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
Several analysts recently weighed in on AVAH shares. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a report on Friday, March 20th. Truist Financial lifted their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a report on Wednesday. Weiss Ratings downgraded shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, April 6th. Royal Bank Of Canada increased their price target on shares of Aveanna Healthcare from $9.00 to $10.00 and gave the stock a “sector perform” rating in a research note on Friday, May 15th. Finally, BMO Capital Markets decreased their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research note on Friday, March 20th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $10.50.
Read Our Latest Research Report on AVAH
Aveanna Healthcare Company Profile
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
See Also
- Five stocks we like better than Aveanna Healthcare
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
